We are live on
!
Find out more
Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$39.1B
1-Year Est. Return
28.69%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$30.7B
AUM Growth
-$1.16B
(-3.6%)
Cap. Flow
-$167M
Cap. Flow
% of AUM
-0.54%
Top 10 Holdings %
Top 10 Hldgs %
37.44%
Holding
630
New
71
Increased
203
Reduced
261
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$352M |
| 2 |
UnitedHealth
UNH
|
+$216M |
| 3 |
Constellation Brands
STZ
|
+$175M |
| 4 |
Elevance Health
ELV
|
+$132M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$129M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$229M |
| 2 |
Intuitive Surgical
ISRG
|
+$226M |
| 3 |
Coca-Cola
KO
|
+$138M |
| 4 |
Wells Fargo
WFC
|
+$76.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$73.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.53% |
| 2 | Healthcare | 23.35% |
| 3 | Financials | 11.26% |
| 4 | Communication Services | 10.36% |
| 5 | Consumer Discretionary | 8.27% |
Similar funds
HF
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2024 Portfolio in Review
As of Q4 2024, Grantham, Mayo, Van Otterloo & Co (GMO) held 630 positions worth $30.7B, down 3.6% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2024 filing shows 71 new, 203 increased, 261 reduced and 60 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 218,200 shares worth $128M. The largest sale was TJX Companies, an estimated $229M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q4 2024 buy was iShares Core S&P 500 ETF: 218,200 shares worth $128M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Thermo Fisher Scientific in Q4 2024, an estimated $352M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q4 2024 reduction was TJX Companies, cutting an estimated $229M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $38.4M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 37% of its $30.7B portfolio in Q4 2024.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 71 new positions and closed 60 in Q4 2024.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 3.6% quarter-over-quarter to $30.7B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2024, filed 13 Feb 2025.